| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K33199242 |
| PharmacoGx | BRD-K33199242 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | METTL5 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | DCLRE1A | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | HAS2 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | PCDHGA4 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | PSMA4 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | ARHGEF18 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | NUDC | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | LRRIQ1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | GRM4 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | ZSCAN22 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
